Breast Cancer Clinical Trials

Showing 2781-2800 of 4,817 trials

RecurIndex Predicts Risk of Recurrence in Early-stage Luminal Breast Cancer

NCT04972448

This study will conduct a multicenter, open, prospective clinical trial to observe the RecurIndex to assist in predicting the risk of recurrence in patients with early-stage Luminal-type breast cancer. The aim of this study is to validate the predictive effect of the RecurIndex on the risk of recurrence in women with early-stage Luminal-type breast cancer in China.

Breast CancerRecurrence

Zhejiang Cancer Hospital500 participantsStarted Jul 2021

UNKNOWNPhase 2

Oral Etoposide Combined With Anlotinib in Advanced Triple Negative Breast Cancer

NCT04452370

The hypothesis of this study is to discover if the oral Etoposide plus Anlotinib can shrink or slow the growth of pretreated advanced TNBC. It is a single-arm, multicenter phase II clinical study of oral etoposide combined with antinib in the treatment of recurrent or metastatic triple-negative breast cancer

Triple Negative Breast Cancer

Chinese Academy of Medical Sciences100 participantsStarted Sep 2020

Beijing, China

RECRUITINGNA

Breast Mesh Used in Two-staged Breast Reconstruction

NCT04967976

This is the first prospective randomized and controlled study on the efficacy and safety of TiLOOP® Bra mesh in patients with expander-implant breast reconstruction. The investigators hypothesize that incoporating TiLOOP Bra mesh with tissue expanders will reduce the rates of capsular contraction, improve the efficiency of expansion and provide better aesthetic result.

Breast CancerRadiationBreast Reconstruction+1 more

Tianjin Medical University Cancer Institute and Hospital300 participantsStarted Aug 2021

Houston, Texas, United States • Lanzhou, Gansu, China • Ch’ang-ch’un, Jilin, China +3 more locations

RecurIndex Predicts Risk of Recurrence in Early-stage Luminal Breast Cancer

Oral Etoposide Combined With Anlotinib in Advanced Triple Negative Breast Cancer

Breast Mesh Used in Two-staged Breast Reconstruction

Related Searches

Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCT

Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer

Palbociclib Combined With an Aromatase Inhibitor in Breast Cancer

Diet and Physical Activity Changes Among Latina Breast Cancer Survivors

Managed Access Program to Provide Alpelisib for Patients With HR+ Advanced or Metastatic Breast Cancer

Folate Receptor Alpha Peptide Vaccine With GM-CSF in Patients With Triple Negative Breast Cancer

Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients

Pyrotinib and Vinorelbine Tartrate Capsules With or Without Inetetamab for First Line Treatment in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer

Evaluation of Heart Function in Breast Cancer Patients Using Trastuzumab

Optoacoustic Images Versus Imagio® Ultrasound

Nab-paclitaxel Based Regimens VS Paclitaxel Based Regimens in Neoadjuvant Treatment for TNBC

Ph3 Study of Exemestane With or Without Entinostat in Chinese Patients With Hormone Receptor-Positive, Locally Advanced or Metastatic Breast Cancer

Assessment of Health Related Quality of Life in Women Who Underwent Breast Reconstruction After Radical Surgery

Efficacy Study of MCS110 Given With Carboplatin and Gemcitabine in Advanced Triple Negative Breast Cancer (TNBC)

Exercise Regimen Designed to Improve Functional Mobility, Body Composition, and Strength After Breast Conservation Therapy for Women With Early Stage Breast Cancer

Can HER2 Targeted PET/CT Imaging Identify Unsuspected HER2 Positive Breast Cancer Metastases, Which Are Amenable to HER2 Targeted Therapy?

Circulating Fetal Cells and Breast Cancer